PiperSandler News & Analysis
12 articles
Market Mood
Stellantis Stock Rating Cut by Piper Sandler on Margin Concerns
Piper Sandler has lowered its rating for Stellantis due to concerns over profit margins. The specific reasons for this downgrade were not detailed, but market reactions often indicate potential impacts on the company's stock price. A reduction in ratings can affect investor confidence and trading volumes, making it crucial for stakeholders to monitor Stellantis (STLA). This situation highlights the importance of analyst ratings in influencing market sentiment and investment strategies.
Read More: Stellantis Stock Rating Cut by Piper Sandler on Margin Concerns
Rivian (RIVN) Stock Upgraded Following R2 Launch and Demand Spike
Piper Sandler upgraded Rivian Automotive (RIVN) stock on the grounds of the R2 vehicle launch and expected increased demand. The firm highlighted the potential for significant market interest surrounding the R2, which could enhance Rivian's sales and overall valuation. This upgrade may positively influence investor perception and stock performance as Rivian works to establish its presence in the competitive electric vehicle market. For ordinary investors, this upgrade suggests a growing confidence in Rivian's future sales growth and market share.
Read More: Rivian (RIVN) Stock Upgraded Following R2 Launch and Demand Spike
Synopsys (SNPS) Upgraded to Overweight by Piper Sandler with $550 Target
On June 23, Piper Sandler upgraded Synopsys, Inc. (SNPS) to 'Overweight' from Neutral, raising the price target from $450 to $550. Analyst Clarke Jeffries highlighted expectations of a faster recovery in Synopsys' intellectual property business, influenced by Intel's improvements in manufacturing. Synopsys recently settled with Elliott Investment Management, which led to the appointment of Jesse Cohn to its board. This shift aims to enhance margins and financial execution while positioning Synopsys to benefit from rising AI investments.
Read More: Synopsys (SNPS) Upgraded to Overweight by Piper Sandler with $550 Target
Microsoft (MSFT) Shares Down 14.6% as UBS Maintains Buy Rating
Microsoft Corporation (MSFT) shares are down 14.6% in the past year and 15% year-to-date. UBS maintained a Buy rating on MSFT on June 7, reflecting confidence in the cloud computing sector. Piper Sandler reiterated an Overweight rating for MSFT with a $540 price target, noting potential for more than five million new Copilot seats due to recent feature enhancements. Jim Cramer expressed skepticism about the need for Microsoft to raise $100 billion, indicating caution in the current market environment.
Read More: Microsoft (MSFT) Shares Down 14.6% as UBS Maintains Buy Rating
Piper Sandler Forecasts Oil Prices to Rise Amid Hormuz Closure
Piper Sandler predicts that the Strait of Hormuz will remain largely closed for months, leading to a potential rise in oil prices. Currently, WTI crude futures are trading around $94 per barrel, down from nearly $120 at the conflict's onset. The bank expressed little confidence that the commercial traffic through the Strait would return to even 50% of its pre-crisis levels soon. This situation could exacerbate shortages and impact global economies reliant on Middle Eastern oil and LNG exports, raising concerns about the overall market.
Read More: Piper Sandler Forecasts Oil Prices to Rise Amid Hormuz Closure
Arista Networks (ANET) Price Target Raised to $181 by Piper Sandler
Piper Sandler raised Arista Networks, Inc.'s (ANET) price target from $175 to $181 and maintained an Overweight rating. The firm's analysis indicates that despite a 35% increase in shares over the past month, investors have become cautious due to rising concerns over growth and de-commitments. However, Arista is expected to maintain solid growth through 2026, supported by its positioning in AI markets. Notably, ANET's 5-year return has outperformed the S&P 500 by 538%.
Read More: Arista Networks (ANET) Price Target Raised to $181 by Piper Sandler
AnaptysBio (ANAB) Price Target Reduced to $93 Amid Spinoff Completion
AnaptysBio, Inc. (ANAB) has had its price target cut by Piper Sandler from $95 to $93 while maintaining an Overweight rating. This adjustment followed the completion of the First Tracks Biotherapeutics (TRAX) spinoff announced in April 2026, transitioning ANAB to operate as a royalty management company. Additionally, on April 24, the Delaware Chancery Court dismissed a breach of contract claim against AnaptysBio by Tesaro, affirming that the company did not repudiate its agreements with Tesaro regarding Jemperli. These developments could influence investor sentiment and market performance for ANAB.
Read More: AnaptysBio (ANAB) Price Target Reduced to $93 Amid Spinoff Completion
Becton Dickinson (BDX) Price Target Trimmed to $159 by Piper Sandler
Piper Sandler has reduced the price target for Becton, Dickinson and Company (BDX) from $170 to $159 while maintaining a Neutral rating. This adjustment was made on April 17, 2026, to align with management's revenue growth guidance. Additionally, RBC Capital Markets lowered its price target for BDX to $175 from $195, citing stable fundamentals in the MedTech sector. Both firms note that current sentiment around BDX may create investment opportunities, but they expect the stock to remain range-bound due to a lack of clear catalysts.
Read More: Becton Dickinson (BDX) Price Target Trimmed to $159 by Piper Sandler
Charles Schwab (SCHW) Price Target Cut Due to AI Concerns
Piper Sandler has lowered the price target for Charles Schwab (SCHW), citing concerns related to artificial intelligence. The adjusted target reflects the firm's outlook amid increased competition and the potential impact of AI on financial services. Analysts are monitoring these developments closely as they may influence investor sentiment and market performance. The stock's performance amid these changes could be pivotal for investor decisions in the coming quarters.
Read More: Charles Schwab (SCHW) Price Target Cut Due to AI Concerns
Nike (NKE) Shares Down 30% This Year, Still Not Cheap
Piper Sandler has stated that Nike (NKE) shares have experienced a 30% decline this year. Despite this drop, analysts suggest that the shares remain overpriced. The assessment indicates that even after the significant drawdown, the company's stock does not present a buying opportunity at current levels. This perspective may influence investor sentiment and market behavior around Nike shares moving forward.
Read More: Nike (NKE) Shares Down 30% This Year, Still Not Cheap
Bank stock buybacks seen as catalyst amid pullback, says Piper Sandler
Piper Sandler notes that bank stock buybacks could serve as a catalyst in the current market pullback. The firm highlights that buybacks can enhance earnings per share and support stock prices, particularly when trading volumes are lower. As banks initiate repurchase programs, the impact on their share prices may be significant. This trend is relevant to investors considering the overall health and performance of the banking sector amid fluctuating conditions.
Read More: Bank stock buybacks seen as catalyst amid pullback, says Piper Sandler
Bill Ackman's Strategy: Aiming for a Berkshire-Hathaway Style Investment Model
Billionaire investor Bill Ackman is aspiring to replicate the successful investment model of Berkshire Hathaway, as assessed by Piper Sandler. The investment firm notes that Ackman's strategy will hinge on effectively managing insurance risk while maximizing investment returns. This ambition is particularly significant as it highlights a trend among investors looking to leverage insurance funds for broader market growth. Success in this venture could reshape market dynamics and influence investor confidence in alternative investment strategies.
Read More: Bill Ackman's Strategy: Aiming for a Berkshire-Hathaway Style Investment Model